Risk factors of severe COVID-19: a review of host, viral and environmental factors
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …
asymptomatic infections to severe disease and death. Understanding the risk factors of …
[HTML][HTML] SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: a systematic review
S Shenoy - World Journal of Critical Care Medicine, 2021 - ncbi.nlm.nih.gov
BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections
is diagnosed via real time reverse transcriptase polymerase chain reaction (RT-PCR) and …
is diagnosed via real time reverse transcriptase polymerase chain reaction (RT-PCR) and …
Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma
Abstract Plasma SARS-CoV-2 RNA may represent a viable diagnostic alternative to
respiratory RNA levels, which rapidly decline after infection. Quantitative PCR with reverse …
respiratory RNA levels, which rapidly decline after infection. Quantitative PCR with reverse …
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
Prognostic characteristics inform risk stratification in intensive care unit (ICU) patients with
coronavirus disease 2019 (COVID-19). We obtained blood samples (n= 474) from …
coronavirus disease 2019 (COVID-19). We obtained blood samples (n= 474) from …
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes
BACKGROUND SARS-CoV-2 plasma viremia has been associated with severe disease and
death in COVID-19 in small-scale cohort studies. The mechanisms behind this association …
death in COVID-19 in small-scale cohort studies. The mechanisms behind this association …
Severe acute respiratory syndrome coronavirus 2 viremia is associated with coronavirus disease 2019 severity and predicts clinical outcomes
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA
(vRNA) is detected in the bloodstream of some patients with coronavirus disease 2019 …
(vRNA) is detected in the bloodstream of some patients with coronavirus disease 2019 …
COVID-19 in B cell-depleted patients after rituximab: a diagnostic and therapeutic challenge
A Furlan, G Forner, L Cipriani, E Vian, R Rigoli… - Frontiers in …, 2021 - frontiersin.org
B cell-targeting strategies such as rituximab are widely used in B cell hematologic
malignancies, rheumatologic and musculoskeletal diseases and a variety of autoimmune …
malignancies, rheumatologic and musculoskeletal diseases and a variety of autoimmune …
[PDF][PDF] COVID-19: Epidemiology, virology, and prevention
K McIntosh, MS Hirsch, A Bloom - UpToDate. Available online …, 2021 - hoiyhoctphcm.org.vn
Coronaviruses are important human and animal pathogens. At the end of 2019, a novel
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
COVID-19—lessons learned and questions remaining
In this article, the editors of Clinical Infectious Diseases review some of the most important
lessons they have learned about the epidemiology, clinical features, diagnosis, treatment …
lessons they have learned about the epidemiology, clinical features, diagnosis, treatment …
COVID-19: Clinical features
K McIntosh, MS Hirsch, A Bloom - Uptodate Version, 2021 - uptodate.com
Coronaviruses are important human and animal pathogens. At the end of 2019, a novel
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …